Agena Bioscience, a global provider of molecular genetic solutions and Molecular Health, a leader in cloud-based decision support technology for precision medicine, have entered into a strategic partnership, whereby Molecular Health Guide (MH Guide) analysis platform will aid interpretation of raw data generated by Agena’s MassARRAY System. The agreement conceives a framework by which the two parties will cooperate and collaborate with their respective customer bases.
The relationship is part of Agena Bioscience’s MassARRAY Insights reporting network, a collaboration programme between Agena Bioscience and preeminent molecular analysis platform providers. It serves to connect the unique capabilities of the MassARRAY mass spectrometer with the power of high quality analysis software, to aid in interpretation.
“Agena Bioscience is focused on enabling labs to generate relevant genomic data. Many of our customers with laboratory developed tests have been interested in additional resources for result interpretation. We believe that Molecular Health’s data interpretation applications based on its Dataome knowledge platform can greatly streamline the data analysis and interpretation workflow for these customers, and we are happy to have an experienced partner like Molecular Health”, said Pete Dansky, chief executive officer at Agena Bioscience.
“This partnership will enable Agena’s users with the highest quality clinical interpretations to improve the value of Agena’s MassARRAY for their customers.” said Friedrich von Bohlen, PhD, chief executive officer at Molecular Health. He added “We look forward to coupling Agena Bioscience’s highly scalable MassARRAY System and Molecular Health’s comprehensive molecular data annotation and interpretation applications in order to offer the market at large the value-add of a workflow-centric solution and ultimately informing impactful decisions.”
Agena Bioscience develops, manufactures, and supplies genetic analysis systems and reagents, including the MassARRAY System.
Molecular Health is a computational biomedicine company focused on big-data curation, integration and analytics to enable precision medicine.